Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (561-570 of 710) with videos related to

Pageof 71
Sort By:
Analytical Chemistry|August 14, 2020
Multimodal Imaging Mass Spectrometry to Identify Markers of Pulmonary Arterial Hypertension in Human Lung Tissue Using MALDI-ToF, ToF-SIMS, and Hybrid SIMSSebastiaan Van Nuffel, Marceau Quatredeniers, Alexander Pirkl, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 10, 2022
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertensionLaurent Savale, Marloes Huitema, Oksana Shlobin, et al.
Rheumatology (Oxford, England)|February 2, 2023
In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre studyBenjamin Chaigne, Kevin Chevalier, Athenaïs Boucly, et al.
The European Respiratory Journal|February 20, 2025
A Long-Term Follow-Up Study of Sotatercept for Treatment of Pulmonary Arterial Hypertension: Interim Results of SOTERIAIoana R Preston, David Badesch, Hossein-Ardeschir Ghofrani, et al.
Circulation|February 16, 2018
NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial HypertensionSébastien J Dumas, Gilles Bru-Mercier, Audrey Courboulin, et al.
The Journal of Clinical Investigation|August 3, 2016
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertensionChristophe Guignabert, Carole Phan, Andrei Seferian, et al.
The New England Journal of Medicine|July 26, 2013
A novel channelopathy in pulmonary arterial hypertensionLijiang Ma, Danilo Roman-Campos, Eric D Austin, et al.
Journal of Clinical Immunology|June 10, 2021
Pulmonary Hypertension in Patients with Common Variable ImmunodeficiencyPierre Thoré, Xavier Jaïs, Laurent Savale, et al.
Frontiers in Medicine|March 24, 2022
Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?Romain Le Pennec, Cécile Tromeur, Charles Orione, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2022
Perceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative StudyBertine Flokstra-de Blok, Janwillem Kocks, Hans Wouters, et al.
Pageof 71

Showing results (561-570 of 710) with videos related to

Sort By:
Pageof 71
Analytical Chemistry|August 14, 2020
Multimodal Imaging Mass Spectrometry to Identify Markers of Pulmonary Arterial Hypertension in Human Lung Tissue Using MALDI-ToF, ToF-SIMS, and Hybrid SIMSSebastiaan Van Nuffel, Marceau Quatredeniers, Alexander Pirkl, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 10, 2022
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertensionLaurent Savale, Marloes Huitema, Oksana Shlobin, et al.
Rheumatology (Oxford, England)|February 2, 2023
In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre studyBenjamin Chaigne, Kevin Chevalier, Athenaïs Boucly, et al.
The European Respiratory Journal|February 20, 2025
A Long-Term Follow-Up Study of Sotatercept for Treatment of Pulmonary Arterial Hypertension: Interim Results of SOTERIAIoana R Preston, David Badesch, Hossein-Ardeschir Ghofrani, et al.
Circulation|February 16, 2018
NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial HypertensionSébastien J Dumas, Gilles Bru-Mercier, Audrey Courboulin, et al.
The Journal of Clinical Investigation|August 3, 2016
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertensionChristophe Guignabert, Carole Phan, Andrei Seferian, et al.
The New England Journal of Medicine|July 26, 2013
A novel channelopathy in pulmonary arterial hypertensionLijiang Ma, Danilo Roman-Campos, Eric D Austin, et al.
Journal of Clinical Immunology|June 10, 2021
Pulmonary Hypertension in Patients with Common Variable ImmunodeficiencyPierre Thoré, Xavier Jaïs, Laurent Savale, et al.
Frontiers in Medicine|March 24, 2022
Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?Romain Le Pennec, Cécile Tromeur, Charles Orione, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2022
Perceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative StudyBertine Flokstra-de Blok, Janwillem Kocks, Hans Wouters, et al.
Pageof 71